PVR and non-small cell lung carcinoma: Moreover, positive CD155 expression was correlated with shorter disease-free survival rates (p = 0.0004) in early- or advanced-stage NSCLC patients, which also represented an independent factor for unfavorable outcomes (p = 0.029) [8].